Clinical Trial Update: The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis [Phase 2, Phase 3]

View source ↗

Summary

A Mayo Clinic–led clinical trial update describing Phase 2 and Phase 3 studies on the role of gastroesophageal reflux disease in eosinophilic esophagitis, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis
• Gastroesophageal Reflux Disease

Snippet

Sponsor: Mayo Clinic | Conditions: Eosinophilic Esophagitis, Gastroesophageal Reflux Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-12-06